| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Per Soelberg Sørensen | Q12331359 |
| Ruth Ann Marrie | Q37368469 | ||
| Maria Trojano | Q41721876 | ||
| Gary R. Cutter | Q89543066 | ||
| Stephen C. Reingold | Q116997602 | ||
| Nadia Reider | Q117260030 | ||
| P2093 | author name string | Jeffrey Cohen | |
| Olaf Stuve | |||
| P2860 | cites work | Emerging Therapies for Relapsing Multiple Sclerosis | Q22253063 |
| The science of fibromyalgia | Q24609662 | ||
| A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis | Q27010175 | ||
| Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis | Q28271008 | ||
| Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial | Q30053056 | ||
| The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study | Q30574620 | ||
| Prevalence of celiac disease in multiple sclerosis | Q33840141 | ||
| Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis | Q34134485 | ||
| Fingolimod-associated macular edema: incidence, detection, and management | Q34257297 | ||
| Immune activation in patients with irritable bowel syndrome | Q34612013 | ||
| Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases. | Q34619661 | ||
| Asthma and multiple sclerosis: an inverse association in a case-control general practice population. | Q34976157 | ||
| A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview | Q35181841 | ||
| The prevalence of fibromyalgia in other chronic pain conditions | Q35608619 | ||
| Liver injury associated with the beta-interferons for MS: a comparison between the three products. | Q35674444 | ||
| Association between comorbidity and clinical characteristics of MS. | Q36088967 | ||
| Cumulative impact of comorbidity on quality of life in MS. | Q37109732 | ||
| Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis | Q37217924 | ||
| Epidemiology of autoimmune diseases in Denmark | Q37278627 | ||
| Impact of comorbidity on fatigue management intervention outcomes among people with multiple sclerosis: an exploratory investigation | Q37442442 | ||
| Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life | Q39135188 | ||
| Diseases associated with multiple sclerosis and epilepsy. A population cohort study of 159,200 middle-aged, urban, native Swedes observed over 10 years (1970-79). | Q39312533 | ||
| Respiratory tract rather than cutaneous atopic allergy inversely associate with multiple sclerosis: a case-control study | Q39364903 | ||
| Patterns of comorbidity in elderly patients with multiple sclerosis | Q40509412 | ||
| The incidence and prevalence of fibromyalgia are higher in multiple sclerosis than the general population: A population-based study | Q41068736 | ||
| Association between multiple sclerosis and chronic periodontitis: a population-based pilot study | Q42275549 | ||
| High risk of cardiovascular diseases after diagnosis of multiple sclerosis | Q43549937 | ||
| Renal failure in patients with neurogenic lower urinary tract dysfunction | Q43953503 | ||
| The relation of multiple sclerosis with allergy and atopy: a case control study | Q44084359 | ||
| Comorbidities at multiple sclerosis diagnosis | Q44268803 | ||
| Effect of autoimmune diseases on risk and survival in female cancers | Q44447517 | ||
| Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs | Q44630260 | ||
| Validation of a self-report comorbidity questionnaire for multiple sclerosis | Q44809985 | ||
| Comorbidities amongst patients with multiple sclerosis: a population-based controlled study | Q45176587 | ||
| Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece | Q45259713 | ||
| Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study | Q46136606 | ||
| Prevalence of cataract and pseudophakia/aphakia among adults in the United States | Q46196467 | ||
| "Seeing" in NARCOMS: a look at vision-related quality of life in the NARCOMS registry | Q46755025 | ||
| Increase with age in the prevalence of beta-thalassemia trait among Sicilians | Q47898284 | ||
| Prevalence of disabilities and associated health conditions among adults--United States, 1999. | Q50125384 | ||
| Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis. | Q50433151 | ||
| Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark. | Q50547789 | ||
| Autoimmune disease in families with multiple sclerosis: a population-based study. | Q51750687 | ||
| Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study. | Q51910234 | ||
| Multiple sclerosis and other immunologic diseases. | Q53035131 | ||
| A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis | Q56779757 | ||
| Risk of cataract and glaucoma in patients with multiple sclerosis | Q57086709 | ||
| Risk of Arterial Cardiovascular Diseases in Patients with Multiple Sclerosis: A Population-Based Cohort Study | Q57300407 | ||
| Comorbidity, socioeconomic status and multiple sclerosis | Q57913787 | ||
| Multiple sclerosis and celiac disease: is there an increased risk? | Q60050559 | ||
| Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort | Q63352440 | ||
| Autoimmunity in multiple sclerosis | Q68278584 | ||
| Concurrence of multiple sclerosis and inflammatory bowel disease | Q69706439 | ||
| The occurrence of autoimmune diseases in patients with multiple sclerosis and their families | Q74172566 | ||
| Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation--United States, 2003-2005 | Q79226739 | ||
| Irritable bowel syndrome | Q79331312 | ||
| A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic | Q80836021 | ||
| Subsequent COPD and lung cancer in patients with autoimmune disease | Q83334244 | ||
| Inverse relationship between multiple sclerosis and allergic respiratory diseases | Q83423927 | ||
| Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis | Q83640597 | ||
| Allergy and multiple sclerosis: a population-based case-control study | Q84377729 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| eye disease | Q3041498 | ||
| lung disease | Q3392853 | ||
| musculoskeletal disorder | Q4116663 | ||
| functional gastrointestinal disorder | Q5508825 | ||
| kidney disease | Q1054718 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 332-341 | |
| P577 | publication date | 2014-12-23 | |
| 2015-03-01 | |||
| P1433 | published in | Multiple Sclerosis Journal | Q1952449 |
| P1476 | title | The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review | |
| P478 | volume | 21 |
| Q35181841 | A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview |
| Q31047731 | Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis |
| Q40899032 | Cardiopulmonary fitness is related to disease severity in multiple sclerosis |
| Q88869506 | Comorbid fibromyalgia: A qualitative review of prevalence and importance |
| Q99711402 | Comorbidity in Multiple Sclerosis |
| Q38794935 | Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age. |
| Q47552826 | Diagnostic confounders of chronic widespread pain: not always fibromyalgia |
| Q26751127 | Eclectic Ocular Comorbidities and Systemic Diseases with Eye Involvement: A Review |
| Q64911996 | Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes. |
| Q64059582 | Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors |
| Q35915847 | Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors |
| Q36782915 | Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study |
| Q42319826 | The multiple sclerosis microbiome? |
| Q58128336 | Total Hip and Knee Arthroplasty in Patients with Multiple Sclerosis |
| Q88658966 | Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner |
| Q55174845 | [18F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis. |
Search more.